NCT02265302View on ClinicalTrials.gov

Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

December 31, 1998

Conditions
Healthy
Interventions
DRUG

BIIL 284 oral solution

DRUG

BIIL 284 wetability improved formulation (WIF) tablets

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY